Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:57 PM
Ignite Modification Date:
2025-12-24 @ 6:57 PM
NCT ID:
NCT01524757
Eligibility Criteria:
Inclusion Criteria:
* Patients with hereditary hemochromatosis (HH), homozygous for C282Y, currently treated with phlebotomy as maintenance therapy for at least 12 months with ≥ 3 phlebotomies per year.
* Ferritin level between 50-100 μg/L at start of the inclusion.
* Age: 18 years- 60 years and weight \> 50 kg.
Exclusion Criteria:
* Patients receiving other therapies such as chelating therapy or forced dietary regimen.
* Patients younger than 18 years.
* HH patients with excessive overweight (BMI \> 35).
* Patients who are mentally incapacitated.
* Women being pregnant or expecting/ planning to become pregnant during the one year period of the study.
* Patients with a malignancy.
* Patients already on PPI treatment.
* Patients who experienced side effects of PPI's.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01524757
Study Brief:
Protocol Section:
NCT01524757